24-Apr-2024
No headlines found.
Globe Newswire (Wed, 17-Apr 8:00 AM ET)
Globe Newswire (Mon, 8-Apr 7:00 AM ET)
CareCloud Central Named Best Medical Billing Software of 2024 by SelectHub
Globe Newswire (Thu, 4-Apr 8:00 AM ET)
Globe Newswire (Tue, 26-Mar 8:00 AM ET)
CareCloud Reports Full Year 2023 Results
Globe Newswire (Thu, 21-Mar 7:00 AM ET)
Globe Newswire (Mon, 11-Mar 7:00 AM ET)
CareCloud To Announce Fourth-Quarter and Full-Year 2023 Results on March 21, 2024
Globe Newswire (Mon, 4-Mar 8:30 AM ET)
Globe Newswire (Thu, 22-Feb 9:15 AM ET)
CareCloud's Managed Practice Pediatric Associates of Dayton Joins Dayton Children's Network
Globe Newswire (Thu, 1-Feb 9:00 AM ET)
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.
Carecloud trades on the NASDAQ stock market under the symbol CCLD.
As of April 24, 2024, CCLD stock price declined to $1.11 with 14,919 million shares trading.
CCLD has a beta of 1.38, meaning it tends to be more sensitive to market movements. CCLD has a correlation of 0.03 to the broad based SPY ETF.
CCLD has a market cap of $17.89 million. This is considered a Sub-Micro Cap stock.
Last quarter Carecloud reported $28 million in Revenue and $.05 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.39.
The top ETF exchange traded funds that CCLD belongs to (by Net Assets): VTI, VXF, BSVO, IWC.
CCLD has underperformed the market in the last year with a price return of -67.4% while the SPY ETF gained +24.2%. CCLD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -11.9% and -7.5%, respectively, while the SPY returned +4.6% and -2.7%, respectively.
CCLD support price is $1.10 and resistance is $1.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCLD stock will trade within this expected range on the day.